Toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Helbling, B. (2009). Quality of life (HRQOL) in patients with hepatitis C. In 1st International Symposium on Hepatitis care in substance users (37). Zurich: Stadt Zürich, Stadtspital Waid.
Toggle visibility
Junet, C. (2009). Co-infection with HIV. In 1st International Symposium on Hepatitis care in substance users (39). Zurich: Centre de soins du Plateau.
Toggle visibility
Kastelic, A. (2009). Different ways of approach : Eastern Europe. In 1st International Symposium on Hepatitis care in substance users (51). Zurich: Psychiatric Clinic Ljubljana, Center for Treatment of Drug Addiction.
Toggle visibility
Lindenburg, K. (2009). Hepatitis C testing and treatment among active drug users in Amsterdam : promising results of the Dutch-C project (drug users treatment for chronic hepatitis C). In 1st International Symposium on Hepatitis care in substance users (14). Zurich: Public Health Service of Amsterdam, Cluster Infectious Diseases, Research Department.
Toggle visibility
Matheï, C. (2009). Hepatitis C and protective immunity : a systematic review. In 1st International Symposium on Hepatitis care in substance users (35). Zurich: Katholieke Universiteit Leuven; Free Clinic.
Toggle visibility
Melin, P. (2009). Vaccination : whom? when? against what? In 1st International Symposium on Hepatitis care in substance users (26). Zurich: SOS hépatites.
Toggle visibility
Mousalli, J. (2009). Management of HCV infected IDUs in addiction centers. In 1st International Symposium on Hepatitis care in substance users (25). Zurich: Programme HépatiteC'Toxicomanie (Hep'Tox France).
Toggle visibility
Müllhaupt, B. (2009). HBV/HCV coinfection. In 1st International Symposium on Hepatitis care in substance users (22). Zurich: Universitätsspital Zürich, Klinik für Gastroenterologie und Hepatologie.
Toggle visibility
Randl, K. (2009). Is multi-disciplinary management sufficient to prompt intravenous drug users on opiate maintenance therapy to treat their chronic hepatitis C? In 1st International Symposium on Hepatitis care in substance users (24). Zurich: Hôtel-Dieu (Centre Hospitalier Universitaire de Clermont-Ferrand), Service d'Hépato-Gastroentérologie.
Toggle visibility
Rehak, V., & Krekulova, L. (2009). IDU and HCV treatment : high response and low reinfection rate. In 1st International Symposium on Hepatitis care in substance users (21). Zurich: Remedis.
Toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print